Systolic Heart Failure: Clinical Trials

3 trials for Systolic Heart Failure, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 unknown. 3 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 23Completed 2, Unknown 1
Phase 31Completed 1

Follow Systolic Heart Failure: new trials by email Literature Review of Systolic Heart Failure trials Research Report on Systolic Heart Failure

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
GutHeart: Targeting Gut Microbiota to Treat Heart Failure
Rifaximin, Saccharomyces boulardii - Systolic Heart Failure
Phase 2UnknownOslo University Hospital1502016-03-112019-03-26
Repurposing Probenecid as a Positive Inotrope for the Treatment of Heart Failure
Probenecid 1 gr oral twice daily, Placebo - Systolic Heart Failure
Phase 2CompletedUniversity of Cincinnati202013-03-012015-08-26
Spinal Cord Stimulation For Heart Failure
Spinal cord stimulation system - Systolic Heart Failure
Phase 2 / Phase 3CompletedAbbott Medical Devices202011-04-012019-02-04

Narrower conditions

Heart Failure, Systolic (3)  ·  Heart Failure (2)  ·  Inflammation (1)

Broader conditions

Cardiovascular Diseases (3)  ·  Heart Diseases (3)  ·  Heart Failure (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

Rifaximin (1)

Sponsors

Abbott Medical Devices (1)  ·  Oslo University Hospital (1)  ·  University of Cincinnati (1)

Countries

Australia (1)  ·  Hong Kong (1)  ·  Japan (1)  ·  Norway (1)  ·  United States (1)

Top investigators

Hung-Fat Tse, MD (1)  ·  Lars L Gullestad, MD, Prof (1)

Results publications

PMID 25500165, PMID 29331959, PMID 38331891